| 前收市價 | 13.58 |
| 開市 | 13.58 |
| 買盤 | 15.50 |
| 賣出價 | 16.70 |
| 拍板 | 115.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 13.58 - 13.58 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 258 |
ZacksARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared with treatment with Comirnaty.
ZacksPFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated version of mRNA COVID-19 jab, Comirnaty.
Barrons.comBioNTech Is More Than a Covid-19 Stock. It’s Having a Great September.
Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down.
